Home
Conditions
Gastrointestinal Neoplasms

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,216 public trials 2,046 recruiting studies

Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Completed

GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer

NCT05419362

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations: Ajou University Hospital Gyeonggi-do, South Korea

Seoul National University Bundang Hospital Gyeonggi-do, South Korea

Asan Medical Center Seoul, South Korea

Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

Establishment and Effectiveness Evaluation of a Training System for Confocal Laser Endomicroscopy

NCT06981819

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +10 more
Locations: The First Affiliated Hospital of Naval Medical University Shanghai, China

View Trial Details

Completed

A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors

NCT06549816

Conditions: Adenocarcinoma Of Esophagus, Adnexal Diseases, Bronchial Neoplasms, +44 more
Locations: Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

Jiangsu Province Hospital Nanjing, Jiangsu, China

View Trial Details

Completed

LATA-IBD TRIAL a Controlled Feasibility Study for the Introduction of Transanal Minimally Invasive IPAA-Surgery. Evaluation of Operative Results and Bowel Function After Introducing Transanal IPAA-surgery to Replace Conventional Laparoscopic IPAA-surgery.

NCT07278687

Conditions: Adenoma, Adenomatous Polyposis Coli, Adenomatous Polyps, +22 more
Locations: Sahlgrenska University Hospital/East department Gothenburg, Sweden

View Trial Details

Completed

Preferences of Patients Treated With Oral Cancer Drugs and Informal Caregivers for Pharmaceutical Consultation in Hospital

NCT05970471

Conditions: Behavior, Breast Diseases, Breast Neoplasms, +40 more
Locations: CHU de Besançon Besançon, France

View Trial Details

Completed

A Multicenter Study on the Safety and Functionality Evaluation of Anastomotic Redo Surgery

NCT07279961

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations: Not specified

View Trial Details

Completed

Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

NCT03615326

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Neoplasms, +8 more
Locations: UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) ( Site 0045) Los Angeles, California, United States

Pacific Cancer Care ( Site 0063) Monterey, California, United States

UC Irvine Medical Center/Chao Family Comprehensive Cancer Center ( Site 0050) Orange, California, United States

University of Miami Sylvester Comprehensive Cancer Center - Plantation ( Site 0026) Miami, Florida, United States

View all 192 locations

View Trial Details

Completed

Feasibility Study CORPPS

NCT05406024

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +13 more
Locations: Centre Hospitalier Universtaire Lille, France

View Trial Details

Completed

Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma

NCT04798781

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations: CS Cancer Beverly Hills Beverly Hills, California, United States

CS Cancer at The Angeles Clinic and Research Institute Los Angeles, California, United States

CS Cancer at the Samuel Oschin Cancer Center Los Angeles, California, United States

View Trial Details

Completed

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

NCT04157985

Conditions: Adenocarcinoma, Advanced Solid Tumors, Anal Cancer, +69 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Gastrointestinal Neoplasms

Gastrointestinal Neoplasms trial results

Related conditions